Back
Apellis Pharmaceuticals Vs. Dave Industry Stock Comparison
Buy
54
APLS
Apellis Pharmaceuticals
Last Price:
33.99
Seasonality Move:
15.03%
Buy
99
DAVE
Dave
Last Price:
99.01
Seasonality Move:
73.86%
Buy
54
Apellis Pharmaceuticals (APLS)
is a Buy
Is Apellis Pharmaceuticals a Buy, Sell or Hold?
- The current Apellis Pharmaceuticals [APLS] share price is $33.93. The Score for APLS is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- APLS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
99
Dave (DAVE)
is a Buy
Is Dave a Buy, Sell or Hold?
- The current Dave [DAVE] share price is $98.68. The Score for DAVE is 99, which is 98% above its historic median score of 50, and infers lower risk than normal.
- DAVE is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
APLS Stock Price Chart
What is Apellis Pharmaceuticals's stock price today?
-
The Apellis Pharmaceuticals share price today is $33.93
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APLS is experiencing selling pressure, which indicates risk of future bearish movement.
DAVE Stock Price Chart
APLS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.02 | Buy |
| Relative Strength Index (14 RSI): | 67.53 | Buy |
| Chaikin Money Flow: | -760673 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (26.8 - 31.1) | Buy |
| Bollinger Bands (100): | (28.44 - 38.44) | Buy |
DAVE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 12.57 | Buy |
| Relative Strength Index (14 RSI): | 79.73 | Buy |
| Chaikin Money Flow: | 61535 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (42.26 - 85.52) | Buy |
| Bollinger Bands (100): | (28.73 - 60.47) | Buy |
APLS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 30.95 | Buy |
| 20-day SMA: | 29.37 | Buy |
| 50-day SMA: | 28.86 | Buy |
| 200-day SMA: | 41.67 | Sell |
| 8-day EMA: | 31.59 | Buy |
| 20-day EMA: | 29.96 | Buy |
| 50-day EMA: | 30.37 | Buy |
| 200-day EMA: | 39.21 | Sell |
DAVE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 86.38 | Buy |
| 20-day SMA: | 70.08 | Buy |
| 50-day SMA: | 53.04 | Buy |
| 200-day SMA: | 40.89 | Buy |
| 8-day EMA: | 87 | Buy |
| 20-day EMA: | 74.22 | Buy |
| 50-day EMA: | 58.81 | Buy |
| 200-day EMA: | 40.81 | Buy |
Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.77 per share, and an increase next year of $0.81 per share.
Dave Earnings Growth & DAVE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.66 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $0.39 per share.
Apellis Pharmaceuticals Technical Analysis
| Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Dave Technical Analysis
| Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||